Metagenomi Inc (NASDAQ: MGX) kicked off on Tuesday, up 13.02% from the previous trading day, before settling in for the closing price of $1.69. Over the past 52 weeks, MGX has traded in a range of $1.23-$5.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -3.60%. With a float of $21.80 million, this company’s outstanding shares have now reached $37.38 million.
Let’s determine the extent of company efficiency that accounts for 202 employees. In terms of profitability, gross margin is 100.0%, operating margin of -193.73%, and the pretax margin is -184.18%.
Metagenomi Inc (MGX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Metagenomi Inc is 41.67%, while institutional ownership is 25.44%. The most recent insider transaction that took place on Jun 06 ’25, was worth 348. In this transaction an insider of this company sold 199 shares at a rate of $1.75, taking the stock ownership to the 16,693 shares. Before that another transaction happened on Jun 06 ’25, when Company’s Chief Medical Officer sold 5,239 for $1.75, making the entire transaction worth $9,168. This insider now owns 109,135 shares in total.
Metagenomi Inc (MGX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -3.60% per share during the next fiscal year.
Metagenomi Inc (NASDAQ: MGX) Trading Performance Indicators
Take a look at Metagenomi Inc’s (MGX) current performance indicators. Last quarter, stock had a quick ratio of 5.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.10, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -2.08 in one year’s time.
Technical Analysis of Metagenomi Inc (MGX)
Looking closely at Metagenomi Inc (NASDAQ: MGX), its last 5-days average volume was 0.58 million, which is a drop from its year-to-date volume of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 86.43%.
During the past 100 days, Metagenomi Inc’s (MGX) raw stochastic average was set at 42.77%, which indicates a significant decrease from 96.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1346 in the past 14 days, which was lower than the 0.1394 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5999, while its 200-day Moving Average is $2.1174. However, in the short run, Metagenomi Inc’s stock first resistance to watch stands at $1.9967. Second resistance stands at $2.0833. The third major resistance level sits at $2.2367. If the price goes on to break the first support level at $1.7567, it is likely to go to the next support level at $1.6033. Should the price break the second support level, the third support level stands at $1.5167.
Metagenomi Inc (NASDAQ: MGX) Key Stats
The company with the Market Capitalisation of 71.40 million has total of 37,381K Shares Outstanding. Its annual sales at the moment are 52,300 K in contrast with the sum of -78,060 K annual income. Company’s last quarter sales were recorded 4,130 K and last quarter income was -25,040 K.
